MedPath
HSA Approval

HANLIM HEPARIN SODIUM INJECTION 25,000 iu/5 ml

SIN11035P

HANLIM HEPARIN SODIUM INJECTION 25,000 iu/5 ml

HANLIM HEPARIN SODIUM INJECTION 25,000 iu/5 ml

July 20, 1999

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS, SUBCUTANEOUS

Medical Information

B01AB01

heparin

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

HANLIM PHARMACEUTICAL CO LTD

Active Ingredients

HEPARIN SODIUM

25000 iu/5 ml

Heparin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

HANLIM HEPARIN SODIUM INJECTION 25,000 iu/5 ml - HSA Approval | MedPath